Insights

• November 23, 2011

  Infographic: Establishing a Potent Compound Safety program

  Wondering how to establish a comprehensive potent compound safety program? Don't know where to start? We boil it all down to the key points for you to consider in a handy, attractive, suitable-for-framing infographic. Read more...

• November 4, 2011

  Occupational Exposure Limits: Understanding the Uncertainties

  Occupational exposure limits for active pharmaceutical ingredients (APIs) contain a number of uncertainty factors. To properly apply this OEL, you must understand these uncertainty factors and why they were used. In this telephone interview with Dr. Joe Nieusma, Sr. Toxicologist for Affygility Solutions, Joe discusses some of the reasons that there may be different occupational exposure limits for the same active pharmaceutical ingredient. Read more...

• May 16, 2011

  Category 4 or 5 Potent Compounds: Understanding the Risks

  What are Category 4 or 5 potent compounds and what are some examples? These questions are often presented to the potent compound safety experts at Affygility Solutions. In this article, Dean M. Calhoun, CIH, President and CEO, and Dr. Joe Nieusma, Senior Occupational Toxicologist with Affygility Solutions discuss answers to these questions. Read more...

• August 19, 2010

  EHS thought leaders – a discussion with Michael Connor

  As a 14 year veteran in the environmental, health and safety field, Michael Connor has played an important role in improving the environmental, health and safety performance of Upsher-Smith Laboratories. On July 21st, 2010, Dean Calhoun, President and CEO of Affygility Solutions met with Michael and discussed a variety of issues important to environmental, health and safety professionals. Read more...

• August 15, 2010

  Do health and safety checklists work?

  Early in my career as an environmental, health and safety professional, there was a significant amount of time spent developing environmental, health and safety checklists for performing routine inspections. In some cases, these "checklists" grew to over forty pages in length and covered every possible health and safety aspect. Read more...

• July 27, 2010

  Are you single? Ten recommendations about managing a corporate EHS program in the bioscience industry by yourself

  In this article, the author will provide recommendations on how to effectively manage a bioscience EHS program as a single individual. Read more...

• July 27, 2010

  Top ten OSHA violations in the biotechnology and pharmaceutical industry

  I am often asked "What are the most common OSHA violations that are cited in the biotechnology and pharmaceutical industry?" So with some research on the OSHA website, I created a list of the top ten OSHA violations for the pharmaceutical and biotechnology industry. From over 25 years of EH&S auditing experience, these OSHA violations are consistent with what I’ve seen during a typical compliance audit Read more...

• June 29, 2010

  Potent compounds: 7 things that every EHS professional should know

  Seven things about potent compounds that every pharmaceutical environmental, health and safety professional should know. Review your potent compound safety handling practices and determine your gaps. Read more...

• January 6, 2010

  EHS thought leaders – a discussion with Jeff Holmes

  Dean Calhoun and Jeff Holmes discuss Genzyme Corporation’s superior environmental performance, the challenges of the LEED process, and advice for young environmental professionals. Read more...

• December 1, 2009

  EHS thought leaders – a discussion with Keith Tait

  Dean Calhoun and Keith Tait discuss EH&S industry changes, opportunities, and the future challenges that lie ahead. Read more...